Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease
admin2021-08-27T10:28:55+00:00Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease Authors: Ingrid Swanson Pultz (PvP Biologics, Inc), Malcolm Hill (PvP Biologics, Inc), Joanne M. Vitanza (PvP Biologics, Inc), Clancey Wolf (PvP Biologics, Inc), Lasse Saaby (Bioneer A/S), Tina Liu (Takeda Pharmaceuticals International Co), Peter Winkle (Anaheim Clinical Trials), [...]